Detection and Quantitation of Rubella IgG Antibody: Evaluation and Performance Criteria for Multiple Component Test Products, Specimen Handling, and Use of Test Products in the Clinical Laboratory; Approved Guideline<\/p>\n","protected":false},"excerpt":{"rendered":"
Detection and Quantitation of Rubella IgG Antibody: Evaluation and Performance Criteria for Multiple Component Test Products, Specimen Handling, and Use of Test Products in the Clinical Laboratory; Approved Guideline (NCCLS document I\/LA6-A) is presented in two parts in order to provide a complete review of rubella serology testing. Part I is intended for use primarily by manufacturers to enable them to meet the general product criteria outlined in Section 3, the general performance criteria and specific performance criteria (Sections 4 and 5, respectively), and to implement the validation testing procedures presented in Section 6. Part I should also be useful to clinical laboratories that participate in the validation testing of these products and be of general interest to laboratories in which rubella serological testing is carried out. Part II (formerly NCCLS document I\/LA7-P) is intended to create an awareness of the preanalytical factors related to rubella serology tests that may affect patient care. Sections 8 through 12 recommend procedures for collecting and handling specimens submitted for serological testing and describe the reporting and interpreting of test results. [NCCLS. Detection and Quantitation of Rubella IgG Antibody: Evaluation and Performance Criteria for Multiple Component Test Products, Specimen Handling, and Use of Test Products in the Clinical Laboratory; Approved Guideline. NCCLS document I\/LA6-A (ISBN 1-56238-335-3). NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 1997.]<\/p>\n","protected":false},"featured_media":1904,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_cat":[26],"product_tag":[],"yoast_head":"\n